IIROC Trade Resumption - IntelGenx Technologies Corp.
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2017) - Trading resumes in: Company: IntelGenx Technologies Corp.
2017-12-05 9:43 AM EST
IIROC Trade Halt - IntelGenx Technologies Corp.
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2017) - The following issues have been halted by IIROC: Company:
2017-12-05 9:21 AM EST
IntelGenx Corp. and RedHill Biopharma Ltd Announce Positive Outcome of the Decentralized Procedure for Approval of RIZAPORT(TM) in Europe
The German Federal Institute for Drugs and Medical Devices (BfArM) has confirmed that the European Marketing Authorization Application (MAA) submitted for RIZAPORT™ is approvable under the European Decentralized Procedure. IntelGenx and RedHill will submit the final required documentation to the German and Luxembourg regulatory authorities next week, which is expected to lead to marketing approval of RIZAPORT™ in both countries and, will continue to...
2015-09-10 9:40 AM EDT
IntelGenx Reports Q2 and First Six Months 2015 Results and Provides Corporate Development Update
Revenue up threefold over Q2 and H1 2014 Company achieves $3M milestone payment from Edgemont André Godin, CPA, CA, appointed as Executive Vice-President and CFO Clemens Mayr, appointed Director Moving towards positive cash flow by fiscal year-end Saint Laurent, Quebec--(Newsfile Corp. - August 10, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx") today announced financial results for the three and six months ended June 30,...
2015-08-10 4:10 PM EDT
IntelGenx to Provide Second Quarter 2015 Update on August 10, 2015
Saint Laurent, Quebec--(Newsfile Corp. - August 6, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx"), a leading drug delivery company focused on the development of novel rapidly disintegrating delivery systems as well as oral controlled-release products, today announced that it will release its second quarter 2015 results for the period ended June 30, 2015, on August 10, 2015 at the close of the financial markets. An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President...
2015-08-06 8:00 AM EDT
IntelGenx Announces Appointment of New Director
Saint Laurent, Quebec--(Newsfile Corp. - August 5, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx") today announced that Mr. Clemens Mayr has accepted his appointment to serve on the Company's Board of Directors. Since 2006, Clemens Mayr is a partner of McCarthy Tétrault LLP, a leading Canadian law firm. His practice focusses on M&A and capital markets, both domestic and cross-border. In the course of his practice he has advised corporations and boards...
2015-08-05 4:19 PM EDT
IntelGenx Appoints Andre Godin as New Executive Vice-President and Chief Financial Officer
Saint Laurent, Quebec--(Newsfile Corp. - July 20, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx") today announced that it entered into an employment agreement with André Godin, CPA, CA as Executive Vice-President and Chief Financial Officer effective August 24, 2015. The board has appointed Mr. Godin as Chief Financial Officer effective immediately. The board of directors granted stock options to acquire 600,000 common shares under the 2006 Stock Option Plan to Mr. Godin...
2015-07-20 4:00 PM EDT
IntelGenx Reports Q1, 2015 Results and Provides Corporate Development Update
Saint Laurent, Quebec--(Newsfile Corp. - May 14, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx") today announced financial results for the three months ended March 31, 2015 and provided an update on operational developments. All amounts are in U.S. Dollars, unless otherwise stated.Commenting on the results, Dr. Horst G. Zerbe, President and CEO of IntelGenx said "I am very pleased to report that we generated an operating profit in the first quarter of 2015, which...
2015-05-14 4:35 PM EDT
IntelGenx Announces Management Changes
Saint Laurent, Quebec--(Newsfile Corp. - May 13, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx") announced today that Mr. Paul Simmons has resigned as Chief Financial Officer ("CFO") of IntelGenx and IntelGenx Corp, effective May 22, 2015. The Company has begun a search process for the selection and appointment of a new Chief Financial Officer. The Board thanks Mr. Simmons for his service and contributions to the company and wishes him well in his future endeavours.About IntelGenx:IntelGenx is...
2015-05-13 5:35 PM EDT
IntelGenx Confirms Execution of Lease and Construction Agreements
Saint Laurent, Quebec--(Newsfile Corp. - May 5, 2015) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx", or the "Company") today confirmed that it recently executed both the lease and construction agreements as anticipated, and as announced in IntelGenx' press release dated March 31, 2015. "The signing of both of these agreements represents a significant milestone for IntelGenx" stated Dr. Horst G. Zerbe, President and CEO of IntelGenx. "As previously announced, we plan to establish a state-of-the-art manufacturing facility for the...
2015-05-05 7:41 AM EDT
IntelGenx to Report 2015 First Quarter Update Call on May 15, 2015
Saint Laurent, Quebec--(Newsfile Corp. - May 4, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx"), a leading drug delivery company focused on the development of novel rapidly disintegrating delivery systems as well as oral controlled-release products, today announced that it will release its 2015 first quarter results for the period ended March 31, 2015, on May 14, 2015 at the close of the financial markets.An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and...
2015-05-04 8:00 AM EDT
IntelGenx Provides Q1, 2015 Update on Sales of Forfivo XL(R)
Saint Laurent, Quebec--(Newsfile Corp. - April 22, 2015) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx", or the "Company") today provided an update on the continued sales growth of Forfivo XL® in the USA.According to Symphony Health Solutions, gross sales of Forfivo XL® totaled $4.0 million in the first quarter of 2015, representing an increase of $0.7 million, or 21%, over gross of $3.3 million in the fourth quarter of 2014. In addition, the number of Forfivo XL® prescriptions filled...
2015-04-22 8:00 AM EDT
IntelGenx Announces Analyst Coverage Initiated by Singular Research
Saint Laurent, Quebec--(Newsfile Corp. - April 16, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx") today announced that Singular Research has initiated analyst coverage on IntelGenx.A copy of the research report may be obtained directly from the analyst at Singular Research by contacting Greg Eisen, CFA, on 626-405-0242 or at research@singularresearch.com. All reports on IntelGenx prepared by analysts represent the views of such analysts and are not necessarily those of IntelGenx. IntelGenx is not responsible...
2015-04-16 8:00 AM EDT
IntelGenx Founder, President and CEO Dr. Horst Zerbe Interviewed on Fox Business Network's "After the Bell"
Saint Laurent, Quebec--(Newsfile Corp. - April 10, 2015) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx") today announced its President and CEO Dr. Horst G. Zerbe, was a guest on FOX Business Network's After the Bell (weekdays 4-5PM/ET) on Thursday, April 9, 2015. During the show, Zerbe discussed the company's growth opportunities for its immediate-release, oral film technology, VersaFilm™. As an example, this technology is effective for the treatment of migraines. A replay of the segment can...
2015-04-10 8:44 AM EDT
IntelGenx Grants Stock Options
Saint Laurent, Quebec--(Newsfile Corp. - April 2, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx", or the "Company") announced today that the Company's board of directors granted options to acquire a total of 300,000 common shares under the 2006 Stock Option Plan, as amended.Of the total stock options granted, 50,000 were granted to each of the following non-employee directors; Bernard Boudreau, John Marinucci, Ian Troup and Bernd Melchers. The options have an exercise price of US$0.62 (CAD$0.78),...
2015-04-02 12:09 PM EDT
IntelGenx Reports 2014 Annual Results and Provides Corporate Development Update
Saint Laurent, Quebec--(Newsfile Corp. - March 31, 2015) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the "Company" or "IntelGenx") today announced financial results for its fiscal year ended December 31, 2014 and provided an update on operational developments. All amounts are in U.S. Dollars, unless otherwise stated."IntelGenx closed fiscal 2014 with a very healthy bank balance, continuing strong sales growth of Forfivo XL®, and excellent R&D progress on our most promising VersaFilm™ projects", said Dr. Horst G. Zerbe, President...
2015-03-31 8:00 AM EDT
IntelGenx to Report 2014 Annual Results and Provide Corporate Development Update on March 31, 2015
Saint Laurent, Quebec--(Newsfile Corp. - March 23, 2015) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx", or the "Company") a leading drug delivery company focused on the development of novel rapidly disintegrating delivery systems as well as oral controlled-release products, today announced that it will release its 2014 annual results for the period and full year ended December 31, 2014, on March 31, 2015 at the open of the financial markets.An accompanying conference call will be hosted by Dr. Horst...
2015-03-23 8:00 AM EDT
IntelGenx Provides Update on Sales of Forfivo XL(R)
Saint Laurent, Quebec--(Newsfile Corp. - February 23, 2015) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx", or the "Company") today provided an update on sales and marketing activities for Forfivo XL®, the Company's first FDA-approved product that was launched in the USA in October 2012 under an exclusive commercialization agreement with Edgemont Pharmaceuticals LLC ("Edgemont"). According to Symphony Health Solutions, gross sales of Forfivo XL® totaled $8.9 million in the year ending December 31st, 2014, an increase of 230% compared...
2015-02-23 8:00 AM EST
IntelGenx to Present at the 8th Annual OneMedForum
Saint Laurent, Quebec--(Newsfile Corp. - January 5, 2015) - IntelGenx Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx") today announced that Dr. Horst Zerbe, Chairman, President and Chief Executive Officer, will present at the 8th Annual OneMedForum to be held Monday, January 12, 2015 at the San Francisco Marriott Marquis. IntelGenx' presentation will take place January 12, 2015 at 10:40 A.M. Pacific Time. Institutional investors that wish to request a meeting with IntelGenx should contact The Cockrell Group. About IntelGenx: IntelGenx is a...
2015-01-05 8:00 AM EST
IntelGenx Grants Stock Options
Saint Laurent, Quebec--(Newsfile Corp. - December 8, 2014) - IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) ("IntelGenx", or the "Company") announced today that the Company's board of directors granted options to acquire 175,000 common shares under the 2006 Stock Option Plan as amended. Of the total stock options granted, 25,000 were granted to each of the following non-employee directors Bernard Boudreau, Ian Troup and Bernd Melchers, 25,000 were granted to each of Horst G. Zerbe, the Chief Executive Officer and...
2014-12-08 2:46 PM EST